Robert F. "Bob" Baltera Jr.

About

Robert F. "Bob" Baltera Jr. is a biotechnology executive, board member, Entrepreneur in Residence, and Senior Advisor at Frazier Life Sciences. He previously led Cirius Therapeutics and Amira Pharmaceuticals, whose sale to Bristol Myers Squibb included $325 million upfront plus potential milestones. Public biographies list an MBA, an MS in genetics, and a BS in microbiology; no PhD was verified.

Areas of interest